Adolfo Garcia-Sastre

Well, it's frustrating, right?

I think the money is there, but it's impossible to manage the program on time to be able to renew it again because of the amount of changes that have been in NIH.

It's also the amount of money that has been put into this program already.

It's not trivial, and we are not able to put this material that we have right now into humans.

Then it will be lost, and if we want to, in the future, to do it, we need to start again making this material.

In my lifetime, I hope so.

But in the next five years, I think it's a big challenge because we want to prove not only that it prevents flu the year that we give the vaccine,

but also prevents flu the second year, the third year, and the fourth year, right?

So just to prove that we have a vaccine that protects for four years requires four years of follow-up.

I am.

If not, I will not be working on it.

But who knows?

You know, I've also tried not to become depressive at the end.

This doesn't move forward, right?

At least, you know, I really would love if we can prove that this is the way for a flu vaccine.

But, you know, to me, the discovery process, you know, to me is very exciting also, whether we can translate it for the good of humanity, even better.

But just to find new mechanisms is very rewarding for scientists.

Okay, good.